Abstract
ObjectivesTo determine the predictive value of the multi-biomarker disease activity (MBDA) (Vectra® DA) score for flare and sustained clinical remission after discontinuation of adalimumab (ADA) in patients with rheumatoid arthritis...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have